HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Early prone positioning therapy for patients with mild COVID-19 disease.

AbstractOBJECTIVE:
In December 2019, Wuhan, China, experienced an outbreak of coronavirus disease 2019 (COVID-19). Some patients admitted to our hospital were treated with early prone positioning (PP). Here, we analyzed its clinical significance.
METHODS:
This was a retrospective observational study. We defined the early PP group as mild COVID-19 patients who were placed into a prone position within 24h of admission; others served as the control group. We recorded basic data and outcomes of early PP and compared the results to those of controls.
RESULTS:
After 1 day of treatment, oxygenation was greater in the early PP group than in the control group (P/F: 421.6±39.74 vs. 382.1±38.84mmHg [1mmHg=0.133kPa], p<0.01). And early PP group spent less total time in prone position (11.1±4.17 vs. 16.9±5.20 days, p<0.01), and required shorter hospitalization duration (12.2±4.49 vs. 23.2±4.83 days, p<0.001).
CONCLUSIONS:
Early PP treatment can improve hypoxia and shorten the prone position time and hospitalization duration in mild COVID-19 patients. It is a potential clinically applicable intervention.
AuthorsXiaoyi Liu, Hui Liu, Qing Lan, Xiangde Zheng, Jun Duan, Fanwei Zeng
JournalMedicina clinica (Med Clin (Barc)) Vol. 156 Issue 8 Pg. 386-389 (04 23 2021) ISSN: 1578-8989 [Electronic] Spain
PMID33478810 (Publication Type: Journal Article, Observational Study)
CopyrightCopyright © 2020 Elsevier España, S.L.U. All rights reserved.
Topics
  • Adult
  • COVID-19 (therapy)
  • China (epidemiology)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Patient Positioning
  • Prone Position

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: